ZCOR Insider Trading Activity and SEC Form 4 Filings
ZCOR insider trading summary
No open-market insider purchases or sales of Zyla Life Sciences (ZCOR) have been reported on SEC Form 4 in the past 12 months.
Latest ZCOR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 30, 2019 | Riva Ridge Capital Management LP | Insider | Sell | $125K (50,000 @ $2.50) |
| Dec 30, 2019 | Riva Ridge Gp LLC | Insider | Sell | $125K (50,000 @ $2.50) |
| Dec 30, 2019 | Stephen H Golden | Insider | Sell | $125K (50,000 @ $2.50) |
| Dec 30, 2019 | James Shim | Insider | Sell | $125K (50,000 @ $2.50) |
| Dec 23, 2019 | Riva Ridge Gp LLC | Insider | Sell | $625K (250,000 @ $2.50) |
| Dec 23, 2019 | Stephen H Golden | Insider | Sell | $625K (250,000 @ $2.50) |
| Dec 23, 2019 | Riva Ridge Capital Management LP | Insider | Sell | $625K (250,000 @ $2.50) |
| Dec 23, 2019 | James Shim | Insider | Sell | $625K (250,000 @ $2.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.